Worldwide Single Cell Multiomics Industry to 2027 - Featuring 10x Genomics, Becton Dickinson and Bio-RAD Laboratories Among Others

DUBLIN, March 9, 2022 /PRNewswire/ -- The "Worldwide Single Cell Multiomics Industry" report has been added to ResearchAndMarkets.com's offering.

The global single cell multiomics market reached a value of US$ 2.85 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.73 Billion by 2027, exhibiting a CAGR of 17.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, they are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor

Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories

Single Cell Multiomics Market Trends:

The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth.

Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global single cell multiomics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product type, technique, application and end user

Breakup by Type:

• Single Cell Genomics
• Single Cell Proteomics
• Single Cell Transcriptomics
• Single Cell Metabolomics

Breakup by Product Type:

• Consumables
• Instruments
• Software

Breakup by Technique:

• Single-Cell Isolation and Dispensing
• Single-Cell Analysis

Breakup by Application:

• Oncology
• Cell Biology
• Neurology
• Others

Breakup by End User:

• Academic Institutes
• Contract Research Organizations
• Pharmaceutical and Biotech Companies

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc

Key Questions Answered in This Report:

• How has the global single cell multiomics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global single cell multiomics market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the product type?
• What is the breakup of the market based on the technique?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global single cell multiomics market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Single Cell Multiomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Single Cell Genomics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Single Cell Proteomics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Single Cell Transcriptomics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Single Cell Metabolomics
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Product Type
7.1 Consumables
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Instruments
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Technique
8.1 Single-Cell Isolation and Dispensing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Single-Cell Analysis
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by Application
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cell Biology
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Neurology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast

10 Market Breakup by End User
10.1 Academic Institutes
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Contract Research Organizations
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical and Biotech Companies
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 10x Genomics Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 BGI Genomics (BGI Group)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bio-RAD Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Fluidigm Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Illumina Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Mission Bio
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 NanoCellect Biomedical
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Nanostring Technologies Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Proteona
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Takara Bio Inc. (Takara Holdings)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/oh54kq

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets